FSRT

RADIATION3 trials

Sponsors

Haaglanden Medical Centre, Sun Yet-Sen University Cancer Center, Sun Yat-sen University

Conditions

BevacizumabBrain MetastasesLung AdenocarcinomaMultiple Brain Metastases in Lung AdenocarcinomaRadiotherapy, Intensity-ModulatedWhole-Brain Radiotherapy

Phase 3

FSRT Combines With Bevacizumab for Multiple Brain Metastases in Lung Adenocarcinoma

RecruitingNCT07058428

Sun Yet-Sen University Cancer CenterMultiple Brain Metastases in Lung Adenocarcinoma

Start: 2025-06-30End: 2028-12-30Target: 258Updated: 2025-12-02

Bevacizumab Plus FSRT Versus Hippocampus-Avoidant WBRT in Lung Adenocarcinoma With Extensive Brain Metastases

Not yet recruitingNCT07481786

Sun Yat-sen UniversityBevacizumab, Brain Metastases, Lung Adenocarcinoma +2

Start: 2026-03-15End: 2029-09-15Target: 220Updated: 2026-03-19

Unknown Phase

Improving Therapeutic Ratio With Hypo Fractionated Stereotactic Radiotherapy for Brain Metastases

RecruitingNCT05346367

Haaglanden Medical CentreBrain Metastases

Start: 2022-07-18End: 2027-03-31Target: 130Updated: 2024-03-12

Related Papers

SAFESTEREO: phase II randomized trial to compare stereotactic radiosurgery with fractionated stereotactic radiosurgery for brain metastases

BMC Cancer2023-03-2515 citations